decreased circulating insulin level_Prkaa2<tm1.1Vio>/Prkaa2<tm1.1Vio>

http://metadb.riken.jp/0002727I129S2SvPasC57BL6Prkaa2tm11VioPrkaa2tm11VioPrkaa2tm11Vio

decreased circulating insulin level_Prkaa2<tm1.1Vio>/Prkaa2<tm1.1Vio>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• protein kinase, AMP-activated, alpha 2 catalytic subunit
  http://metadb.riken.jp/db/mgi_rdf/MGI:1336173

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Prkaa2<tm1.1Vio>/Prkaa2<tm1.1Vio>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Prkaa2<tm1.1Vio>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S2/SvPas * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased circulating insulin level
  http://purl.obolibrary.org/obo/MP_0002727

文献

http://purl.org/net/cito/citesAsAuthority

• Benoit. Viollet, et.al., The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity., The Journal of clinical investigation, 2003, 111
  http://rdf.ncbi.nlm.nih.gov/pubmed/12511592